Vascular structure and stiffness in pediatric Mulibrey nanism using ultra-high frequency ultrasound

Submitted: 17 September 2023
Accepted: 20 November 2023
Published: 30 November 2023
Abstract Views: 1130
PDF: 52
HTML: 1
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Mulibrey nanism (MUL) is a disorder with growth delay and congestive heart failure determining prognosis. We aimed to delineate arterial and venous morphology, and arterial stiffness in a representative pediatric MUL cohort. Twenty-three MUL and 23 individually sex and age-matched healthy controls were prospectively assessed in a cross-sectional study with ultra-high frequency ultrasound (48-70 MHz). Heart failure was present in 7 MUL patients, with severe congestive heart failure in 2. Pericardiectomy had been performed in 6 MUL. Arterial lumen diameters and arterial wall layer thickness (intima-media thickness and adventitia thickness) were smaller in MUL patients, but appropriate for body size when compared with controls. Systolic and diastolic blood pressure, aortic and carotid compliance, stiffness as well as central aortic pulsed wave velocity were all similar in MUL compared with controls. Plasma pro-BNP levels were variably elevated (>300 ng/L) in 9/23 MUL patients and in 4/18 MUL patients older than 5 years of age. Internal jugular vein (mean difference 0.054 mm, CI95% 0.024-0.084) and cubital vein (0.046 mm, CI95% 0.013 - 0.078) total wall thickness was elevated in MUL compared with controls. There were no statistically significant relations between vascular parameters and clinical or laboratory signs of heart failure or pericardiectomy. Arterial lumen, wall layer thickness and stiffness are appropriate for body size in MUL, and like healthy controls. Mild venous wall thickening in the upper body region may be due to increased venous pressures related to remodelling caused by diastolic heart failure.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Avela K, Lipsanen-Nyman M, Perheentupa J et al. Assignment of the mulibrey nanism gene to 17q by linkage and linkage-disequilibrium analysis. Am J Hum Genet. 1997;60:896–902.
Avela K, Lipsanen-Nyman M, Idänheimo N et al. Gene encoding a new RING-B-box- coiled-coil protein is mutated in mulibrey nanism. Nat Genet. 2000;25:298–301. DOI: https://doi.org/10.1038/77053
Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M. Mulibrey nanism: clinical features and diagnostic criteria. J Med Genet. 2004;41:92-98. DOI: https://doi.org/10.1136/jmg.2003.014118
Karlberg N, Karlberg S, Karikoski R et al. High frequency of tumours in Mulibrey nanism. J Pathol. 2009;218:163-171. DOI: https://doi.org/10.1002/path.2538
Perheentupa J, Autio S, Leisti S, Raitta C. Mulibrey-nanism: Dwarfism With Muscle, Liver, Brain and Eye Involvement. Acta Paediatr Scand Suppl. 206:Suppl 1970;206:74 DOI: https://doi.org/10.1111/j.1651-2227.1970.tb14591.x
Perheentupa J, Autio S, Leisti S et al. Mulibrey nanism, an autosomal recessive syndrome with pericardial constriction. Lancet. 1973;2:351–355. DOI: https://doi.org/10.1016/S0140-6736(73)93193-0
Tuuteri L, Perheentupa J, Rapola J. The cardiopathy of mulibrey nanism, a new inherited syndrome. Chest. 1974;65:628-631. DOI: https://doi.org/10.1378/chest.65.6.628
Lipsanen-Nyman M, Perheentupa J, Rapola J et al. Mulibrey heart disease: clinical manifestations, long-term course, and results of pericardiectomy in a series of 49 patients born before 1985. Circulation. 2003;107:2810-2815. DOI: https://doi.org/10.1161/01.CIR.0000070949.76608.E2
Kivistö S, Lipsanen-Nyman M, Kupari M et al. Cardiac involvement in Mulibrey nanism: Characterization with magnetic resonance imaging. J. Cardiovasc. Magn. Reson. 2004;6,645–652. DOI: https://doi.org/10.1081/JCMR-120038085
Eerola A, Pihkala JI, Karlberg N et al. Cardiac dysfunction in children with Mulibrey nanism. Pediatr Cardiol. 2007;28(3):155-162 DOI: https://doi.org/10.1007/s00246-006-0007-2
Sarkola T, Lipsanen-Nyman M, Jalanko H, Jokinen E. Pericardial constriction and myocardial restriction in pediatric Mulibrey nanism – a complex disease with diastolic dysfunction. CJCO. 2021;4(1):28-36. doi: 10.1016/j.cjco.2021.08.012 DOI: https://doi.org/10.1016/j.cjco.2021.08.012
Sivunen J, Karlberg S, Kivisaari R et al. Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism). Liver Int. 2022;42(6):1369-1378. doi: 10.1111/liv.15213 DOI: https://doi.org/10.1111/liv.15213
Sarkola T, Redington AN, Slorach C et al. Assessment of Vascular Phenotype using a Novel Very-High Resolution Ultrasound Technique in Adolescents after Aortic Coarctation Repair and/or Stent Implantation: Relationship to Central Hemodynamics and Left Ventricular Mass. Heart. 2011;97:1788-1793. DOI: https://doi.org/10.1136/hrt.2011.226241
Sarkola T, Manlhiot C, Slorach C et al. Evolution of the Arterial Structure and Function from Infancy to Adolescence is related to Anthropometric and Blood Pressure Changes. ATVB. 2012;32:2516-2524. DOI: https://doi.org/10.1161/ATVBAHA.112.252114
Sarkola T, Jaeggi E, Slorach C et al. Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: Arterial wall thinning and venous thickening in late follow up. Heart Vessels 2013;28:66-75. DOI: https://doi.org/10.1007/s00380-011-0217-2
Hays BS, Baker M, Laib A et al. Histopathological abnormalities in the central arteries and veins of Fontan subjects. Heart. 2018;104:324-331. DOI: https://doi.org/10.1136/heartjnl-2017-311838
Ross RD. The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol. 2012;33:1295-1300. DOI: https://doi.org/10.1007/s00246-012-0306-8
Saari A, Sankilampi U, Hannila ML et al. New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med. 2011;43:235-248. DOI: https://doi.org/10.3109/07853890.2010.515603
Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes. 2012;7:284-294. DOI: https://doi.org/10.1111/j.2047-6310.2012.00064.x
Foster BJ, Platt RW, Zemel BS. Development and validation of a predictive equation for lean body mass in children and adolescents. Ann Hum Biol. 2012;39:171–182. DOI: https://doi.org/10.3109/03014460.2012.681800
National High Blood Pressure Education Program Working Group. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576. DOI: https://doi.org/10.1542/peds.114.2.S2.555
Sarkola T, Redington AN, Keeley F et al. Transcutaneous very-high-resolution ultrasound to quantify arterial wall layers of muscular and elastic arteries: Validation of a method. Atherosclerosis. 2010;212:516-523. DOI: https://doi.org/10.1016/j.atherosclerosis.2010.06.043
Olander RF, Sundholm JK, Ojala TH et al. Neonatal Arterial Morphology Is Related to Body Size in Abnormal Human Fetal Growth. Circ Cardiovasc Imaging. 2016;9(9):e004657. DOI: https://doi.org/10.1161/CIRCIMAGING.116.004657
Sundholm JKM, Litwin L, Rönö K et al. Maternal obesity and gestational diabetes: Impact on arterial wall layer thickness and stiffness in early childhood - RADIEL study six-year follow-up. Atherosclerosis. 2019;284:237-244. DOI: https://doi.org/10.1016/j.atherosclerosis.2019.01.037
Olander RFW, Sundholm JKM, Suonsyrjä S, Sarkola T. Arterial health during early childhood following abnormal fetal growth. BMC Pediatr. 2022;22:40. DOI: https://doi.org/10.1186/s12887-021-02951-2

How to Cite

Sarkola, T., Lipsanen-Nyman, M., Jalanko, H., & Jokinen, E. (2023). Vascular structure and stiffness in pediatric Mulibrey nanism using ultra-high frequency ultrasound. Veins and Lymphatics, 12(1). https://doi.org/10.4081/vl.2023.11826